Diagnostic NATA ISO 15189 Audited over a 4 year Testing Field of Testing – cycle involving online (for example Medical Testing assessment activities, at semen least one Surveillance (Medicare rebates for analyses and visit by a NATA lead eligible tests are only anti-sperm assessor and at least one available to facilities antibody Reassessment visit holding NATA testing) involving an on-site visit accreditation) by NATA lead assessor and technical assessor Clinical RTAC Code of Practice Audited by JAS-ANZ Preparations for Assisted accredited certification (When laboratory is Reproductive bodies over a 3 year (for example part of an Assisted Technology Units cycle, with minimum of preparation of Reproductive yearly surveillance visits IUI samples Technology facility) for auditing of Critical and freezing of Criteria (including semen for identification/traceability future use) processes), whilst Good Practice Criteria auditing occurs at least once per 3 year cycle Recommendation to PASC Following national consultation with patients, parents, partners and health care professionals (doctors, nurses, psychologists, and counselors) and fertility laboratory staff, we are seeking three new oncofertility Medicare item numbers. The new oncofertility Medicare item numbers will allow the development of internationally recognised oncofertility practice in Australia as well as allowing equitable access to all patients requiring fertility preservation. Following the creation of oncofertility Medicare item numbers, insurance agencies supported by the Federal Government, will be encouraged to incorporate oncofertility care into insurance item numbers. This will mean that patients receiving gonadotoxic treatment with medical insurance will have policies, which may cover some or all of the costs of oncofertility care.
Diagnostic Testing (for example semen analyses and anti-sperm antibody testing) NATA Field of Testing – Medical Testing (Medicare rebates for eligible tests are only available to facilities holding NATA accreditation) ISO 15189 Audited over a 4 year cycle involving online assessment activities, at least one Surveillance visit by a NATA lead assessor and at least one Reassessment visit involving an on-site visit by NATA lead assessor and technical assessor Clinical Preparations (for example preparation of IUI samples and freezing of semen for future use) RTAC (When laboratory is part of an Assisted Reproductive Technology facility) Code of Practice for Assisted Reproductive Technology Units Audited by JAS-ANZ accredited certification bodies over a 3 year cycle, with minimum of yearly surveillance visits for auditing of Critical Criteria (including identification/traceability processes), whilst Good Practice Criteria auditing occurs at least once per 3 year cycle Recommendation to PASC Following national consultation with patients, parents, partners and health care professionals (doctors, nurses, psychologists, and counselors) and fertility laboratory staff, we are seeking three new oncofertility Medicare item numbers. The new oncofertility Medicare item numbers will allow the development of internationally recognised oncofertility practice in Australia as well as allowing equitable access to all patients requiring fertility preservation. Following the creation of oncofertility Medicare item numbers, insurance agencies supported by the Federal Government, will be encouraged to incorporate oncofertility care into insurance item numbers. This will mean that patients receiving gonadotoxic treatment with medical insurance will have policies, which may cover some or all of the costs of oncofertility care.
1435-ConsultationProtocol-Accessible.docx